391 related articles for article (PubMed ID: 27026907)
1. Spontaneous adverse drug reaction reporting by patients in Canada: a multi-method study-study protocol.
Dweik RA; Yaya S; Stacey D; Kohen D
Springerplus; 2016; 5():213. PubMed ID: 27026907
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
3. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.
Inch J; Watson MC; Anakwe-Umeh S
Drug Saf; 2012 Oct; 35(10):807-18. PubMed ID: 22928729
[TBL] [Abstract][Full Text] [Related]
4. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL;
Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189
[TBL] [Abstract][Full Text] [Related]
5. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database.
Castillon G; Salvo F; Moride Y
Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742
[TBL] [Abstract][Full Text] [Related]
6. Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey.
Hussain R; Hassali MA; Hashmi F; Akram T
J Pharm Policy Pract; 2021 Jan; 14(1):5. PubMed ID: 33397478
[TBL] [Abstract][Full Text] [Related]
7. Monitoring drug safety in Astrakhan, Russia.
Kirilochev OO; Dorfman IP; Umerova AR
Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
[TBL] [Abstract][Full Text] [Related]
8. Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented.
Abu Esba LC; Al Mardawi G; AlJasser MI; Aljohani B; Abu Alburak A
J Clin Pharm Ther; 2021 Apr; 46(2):460-469. PubMed ID: 33285001
[TBL] [Abstract][Full Text] [Related]
9. How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme.
Hazell L; Cornelius V; Hannaford P; Shakir S; Avery AJ;
Drug Saf; 2013 Mar; 36(3):199-206. PubMed ID: 23444232
[TBL] [Abstract][Full Text] [Related]
10. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
[TBL] [Abstract][Full Text] [Related]
11. Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa.
Terblanche A; Meyer JC; Godman B; Summers RS
Hosp Pract (1995); 2018 Oct; 46(4):221-228. PubMed ID: 30092683
[TBL] [Abstract][Full Text] [Related]
12. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
Inácio P; Airaksinen M; Cavaco A
Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
[TBL] [Abstract][Full Text] [Related]
13. Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.
Khan Z; Karatas Y; Martins MAP; Jamshed S; Rahman H
Curr Med Res Opin; 2022 Jan; 38(1):145-154. PubMed ID: 34694167
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of completeness of suspected adverse drug reaction reports submitted to the mexican national pharmacovigilance centre: a cross-sectional period-prevalence study.
Sánchez-Sánchez B; Altagracia-Martínez M; Kravzov-Jinich J; Moreno-Bonett C; Vázquez-Moreno E; Martínez-Núñez JM
Drug Saf; 2012 Oct; 35(10):837-44. PubMed ID: 22924896
[TBL] [Abstract][Full Text] [Related]
15. Health-care Professionals' Knowledge and Perception of Adverse Drug Reaction Reporting and Pharmacovigilance in a Tertiary Care Teaching Hospital of Nepal.
Danekhu K; Shrestha S; Aryal S; Shankar PR
Hosp Pharm; 2021 Jun; 56(3):178-186. PubMed ID: 34024926
[No Abstract] [Full Text] [Related]
16. Patient Reporting in the EU: Analysis of EudraVigilance Data.
Banovac M; Candore G; Slattery J; Houÿez F; Haerry D; Genov G; Arlett P
Drug Saf; 2017 Jul; 40(7):629-645. PubMed ID: 28417320
[TBL] [Abstract][Full Text] [Related]
17. Important information regarding reporting of adverse drug reactions: a qualitative study.
Rolfes L; Wilkes S; van Hunsel F; van Puijenbroek E; van Grootheest K
Int J Pharm Pract; 2014 Jun; 22(3):231-3. PubMed ID: 23937120
[TBL] [Abstract][Full Text] [Related]
18. Qualitative Study of General Public Views towards Adverse Drug Reactions in Lithuania.
Valinciute-Jankauskiene A; Loreta K
Healthcare (Basel); 2021 Mar; 9(3):. PubMed ID: 33803215
[TBL] [Abstract][Full Text] [Related]
19. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.
Adisa R; Adeniyi OR; Fakeye TO
Int J Clin Pharm; 2019 Aug; 41(4):1062-1073. PubMed ID: 31140162
[TBL] [Abstract][Full Text] [Related]
20. Patients' experiences on adverse drug reactions reporting: a qualitative study.
Al Dweik R; Yaya S; Stacey D; Kohen D
Eur J Clin Pharmacol; 2020 Dec; 76(12):1723-1730. PubMed ID: 32661571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
